REBEKAH EKEMA: Open Payments
NPI 1659049120 · HARRISBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,903 in 155 payments from 28 companies in 2025. Trend: 2023 $2,591 · 2024 $2,287 · 2025 $2,903
Food & beverage: $2,903
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $342 |
| Lilly USA, LLC | 15 | $295 |
| GlaxoSmithKline, LLC. | 21 | $283 |
| Amgen Inc. | 16 | $230 |
| Otsuka America Pharmaceutical, Inc. | 10 | $225 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $201 |
| AstraZeneca Pharmaceuticals LP | 5 | $184 |
| Exact Sciences Corporation | 7 | $141 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $127 |
| PFIZER INC. | 6 | $113 |
Products named: REXULTI, JARDIANCE, TRELEGY ELLIPTA, MOUNJARO, Wegovy, Cologuard Collection Kit, EVENITY, Kerendia.
Industry payments across PA — which companies pay providers there.
